Compile Data Set for Download or QSAR
maximum 50k data
Found 14 of affinity data for UniProtKB/TrEMBL: Q9UF12
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433365(US10562844, Compound 16)
Affinity DataIC50:  2.90E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433361(US10562844, Compound 13)
Affinity DataIC50:  3.20E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433364(US10562844, Compound 14)
Affinity DataIC50:  3.30E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433363(US10562844, Compound 15)
Affinity DataIC50:  3.70E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433359(US10562844, Compound 11)
Affinity DataIC50:  3.70E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433358(US10562844, Compound 10)
Affinity DataIC50:  3.80E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433360(US10562844, Compound 8)
Affinity DataIC50:  4.80E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433357(US10562844, Compound 7)
Affinity DataIC50:  6.00E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433355(US10562844, Compound 9)
Affinity DataIC50:  6.30E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433362(US10562844, Compound 12)
Affinity DataIC50: <1.00E+6nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433354(US10562844, Compound 2)
Affinity DataIC50:  1.50E+6nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433351(US10562844, Compound 5)
Affinity DataIC50:  2.10E+6nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433349(US10562844, Compound 1)
Affinity DataIC50:  2.90E+6nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHydroxyproline dehydrogenase [147-515](Homo sapiens (Human))
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433356(US10562844, Compound 6)
Affinity DataIC50: >1.00E+7nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In DepthDetails US Patent